Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.68 USD | +0.32% |
|
-0.25% | +2.92% |
13/06 | Collegium Pharmaceutical Says Nucynta Gets FDA Pediatric Exclusivity | MT |
13/06 | Collegium Pharmaceutical, Inc. Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.92% | 103.64Cr | |
+51.63% | 80TCr | |
+41.51% | 63TCr | |
-5.10% | 36TCr | |
+19.90% | 33TCr | |
+9.95% | 30TCr | |
+17.66% | 24TCr | |
+3.39% | 23TCr | |
+10.75% | 21TCr | |
+6.99% | 17TCr |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Insider Trends: Collegium Pharmaceutical Insider Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected